Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / SELB - Selecta Biosciences Merges Cartesian To Focus On Autoimmune Cell Therapy | Benzinga

SELB - Selecta Biosciences Merges Cartesian To Focus On Autoimmune Cell Therapy | Benzinga

Selecta Biosciences Inc.

Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta shareholders owning 26.9% of the new company. 

In August, Selecta Biosciences provided an update on its ongoing strategic initiative to maximize stockholder value related to its economic interests in SEL-212, which is being developed for chronic refractory gout, which Selecta Full story available on Benzinga.com
Stock Information
Company Name: Selecta Biosciences Inc.
Stock Symbol: SELB
Market: NASDAQ
Website: selectabio.com
Menu
SELB SELB Quote SELB Short SELB News SELB Articles SELB Message Board
Get SELB Alerts

News, Short Squeeze, Breakout and More Instantly...